With a 25-lakh-square-foot pharmaceutical park in Tyumen, Russia, SRK Pharmaceuticals develops and contract-manufactures drug products and nicotine replacement therapies for international markets. Founded 26 years ago, the company operates 14 manufacturing sites, supported by a global R&D center in Singapore and capabilities spanning oral, injectable, liquid and NRT formulations. Its facilities are described as GMP-compliant and certified or licensed under ISO 13485, FDA, TGA and WHO-related requirements.
Good Manufacturing Practice (GMP)
certification
ISO 13485
certification
Australian Register of Therapeutic Goods (ARTG)
registration
Therapeutic Goods Administration (TGA)
compliance_program
USFDA
compliance_program
APVMA
compliance_program
WHO-GMP
compliance_program
REACH
compliance_program
PMTA
compliance_program
CE Compliance
certification
WHO-GDP
compliance_program